HeiLongJiang ZBD Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -44.20% vs -26.32% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -21,200.00% vs -98.77% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "204.90",
          "val2": "367.20",
          "chgp": "-44.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-333.60",
          "val2": "6.70",
          "chgp": "-5,079.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "41.80",
          "val2": "34.00",
          "chgp": "22.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-295.40",
          "val2": "1.40",
          "chgp": "-21,200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,628.20%",
          "val2": "-76.00%",
          "chgp": "-155.22%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -14.16% vs -25.58% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.67% vs 144.94% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,685.30",
          "val2": "3,128.30",
          "chgp": "-14.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "773.80",
          "val2": "303.30",
          "chgp": "155.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "145.10",
          "val2": "136.90",
          "chgp": "5.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.50",
          "val2": "-0.30",
          "chgp": "-400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "436.40",
          "val2": "467.60",
          "chgp": "-6.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "231.80%",
          "val2": "32.60%",
          "chgp": "19.92%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

204.90

367.20

-44.20%

Operating Profit (PBDIT) excl Other Income

-333.60

6.70

-5,079.10%

Interest

41.80

34.00

22.94%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-295.40

1.40

-21,200.00%

Operating Profit Margin (Excl OI)

-1,628.20%

-76.00%

-155.22%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is -44.20% vs -26.32% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -21,200.00% vs -98.77% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2,685.30

3,128.30

-14.16%

Operating Profit (PBDIT) excl Other Income

773.80

303.30

155.13%

Interest

145.10

136.90

5.99%

Exceptional Items

-1.50

-0.30

-400.00%

Consolidate Net Profit

436.40

467.60

-6.67%

Operating Profit Margin (Excl OI)

231.80%

32.60%

19.92%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -14.16% vs -25.58% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -6.67% vs 144.94% in Dec 2023

All Annual Results